Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zargar

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Indian Journal of Pathology & Microbiology|December 29, 2000
Seroprevalence of toxoplasmosis in women with recurrent abortions/neonatal deaths and its treatment outcomeA H Zargar, A I Wani, S R Masoodi, et al.
Archives of Gynecology and Obstetrics|September 20, 2021
High incidences of chromosomal aberrations and Y chromosome micro-deletions as prominent causes for recurrent pregnancy losses in highly ethnic and consanguineous populationArshad A Pandith, Usma Manzoor, Ina Amin, et al.
Indian Journal of Endocrinology and Metabolism|April 4, 2025
Prevention and Treatment of Vitamin D Deficiency in India: An Expert Group ConsensusSanjay Kalra, Abdul H Zargar, Ashok K Das, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 2, 2019
Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in IndiansAwadhesh Kumar Singh, Ambika G Unnikrishnan, Abdul H Zargar, et al.
The Journal of the Association of Physicians of India|May 1, 2017
Consensus on Insulin Dose and Titration Algorithms in Ambulatory Care of Type 2 Diabetes in IndiaRajiv Kovil, Manoj Chawla, Rajesh Rajput, et al.
Endocrinology, Diabetes & Metabolism|July 1, 2023
The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial)Ashok K Das, Sanjay Kalra, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|February 1, 2023
Two-year trends from the LANDMARC study: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcome in patients with type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Baseline characteristics of participants in the LANDMARC trial: A 3-year, <i>pan</i>-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusAshok K Das, Ambrish Mithal, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|December 2, 2021
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2019
Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusA K Das, A Mithal, K M P Kumar, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Indian Journal of Pathology & Microbiology|December 29, 2000
Seroprevalence of toxoplasmosis in women with recurrent abortions/neonatal deaths and its treatment outcomeA H Zargar, A I Wani, S R Masoodi, et al.
Archives of Gynecology and Obstetrics|September 20, 2021
High incidences of chromosomal aberrations and Y chromosome micro-deletions as prominent causes for recurrent pregnancy losses in highly ethnic and consanguineous populationArshad A Pandith, Usma Manzoor, Ina Amin, et al.
Indian Journal of Endocrinology and Metabolism|April 4, 2025
Prevention and Treatment of Vitamin D Deficiency in India: An Expert Group ConsensusSanjay Kalra, Abdul H Zargar, Ashok K Das, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 2, 2019
Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in IndiansAwadhesh Kumar Singh, Ambika G Unnikrishnan, Abdul H Zargar, et al.
The Journal of the Association of Physicians of India|May 1, 2017
Consensus on Insulin Dose and Titration Algorithms in Ambulatory Care of Type 2 Diabetes in IndiaRajiv Kovil, Manoj Chawla, Rajesh Rajput, et al.
Endocrinology, Diabetes & Metabolism|July 1, 2023
The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial)Ashok K Das, Sanjay Kalra, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|February 1, 2023
Two-year trends from the LANDMARC study: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcome in patients with type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Baseline characteristics of participants in the LANDMARC trial: A 3-year, <i>pan</i>-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusAshok K Das, Ambrish Mithal, Shashank Joshi, et al.
Endocrinology, Diabetes & Metabolism|December 2, 2021
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitusAshok K Das, Sanjay Kalra, Shashank Joshi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 7, 2019
Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitusA K Das, A Mithal, K M P Kumar, et al.
Pageof 7